http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101841238-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-415 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4155 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-427 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-433 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4155 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-415 |
| filingDate | 2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101841238-B1 |
| titleOfInvention | Pharmaceutical Composition Comprising Inhibitor of TRPC3 for Treating Itch |
| abstract | The present invention relates to a pharmaceutical composition for the treatment of itching comprising an inhibitor of TRPC3 (transient receptor potential ion channel, subfamily C, member 3) as an active ingredient. According to the present invention, it is possible to provide a novel method for suppressing and treating chronic itching caused by itching induced by mROS excess production due to mitochondrial dysfunction or dry skin. |
| priorityDate | 2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 206.